Cephlon/Teva seeks buyers for Mesoblast stake, CS in market
Stockbroker Credit Suisse was in the market with a substantial stake in Mesoblast on Tuesday afternoon.
The broker was looking to offload 29 million shares at $1.50 each on behalf of pharmaceutical company Cephlon, which was recently acquired by Teva.
The sale was designed to cut Cephlon/Teva's stake to less than 5 per cent of Mesoblast's shares on issue, investor sources told Street Talk.
The shares were being offered at an 8 per cent discount to their closing price on Tuesday.
The sale comes only two months after Mesoblast launched a $50.7 million equity raising which diluted Cephlon/Teva's stake.
Read more: http://www.copyright link/street-ta...ke-cs-in-market-20171023-gz6sm4#ixzz4wQrI6A5R
Cell Therapy News/Articles, page-70
-
- There are more pages in this discussion • 17,736 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |